Want to see IN:NATCOPHARM full AI Analyst Report?
Total Valuation
NATCO Pharma Limited has a market cap or net worth of ₹156.97B. The enterprise value is ₹153.84B.
Market Cap₹156.97B
Enterprise Value₹153.84B
Share Statistics
NATCO Pharma Limited has 196,167,950 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding196,167,950
Owned by Insiders―
Owned by Institutions0.05%
Financial Efficiency
NATCO Pharma Limited’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 11.34%.
Return on Equity (ROE)0.15
Return on Assets (ROA)0.13
Return on Invested Capital (ROIC)11.34%
Return on Capital Employed (ROCE)0.13
Revenue Per Employee9.20M
Profits Per Employee3.36M
Employee Count4,433
Asset Turnover0.37
Inventory Turnover0.76
Valuation Ratios
The current PE Ratio of NATCO Pharma Limited is 12.5. NATCO Pharma Limited’s PEG ratio is -0.51.
PE Ratio12.5
PS Ratio4.40
PB Ratio1.95
Price to FCF13.03
Price to Operating Cash Flow12.04
PEG Ratio-0.51
Income Statement
In the last 12 months, NATCO Pharma Limited had revenue of 40.78B and earned 14.19B in profits. Earnings per share was 79.21.
Revenue40.78B
Gross Profit33.88B
Operating Income12.30B
Pretax Income15.37B
Net Income14.19B
EBITDA17.34B
Earnings Per Share (EPS)79.21
Cash Flow
In the last 12 months, operating cash flow was 11.91B and capital expenditures -1.80B, giving a free cash flow of 10.10B billion.
Operating Cash Flow11.91B
Free Cash Flow10.10B
Free Cash Flow per Share51.50
Dividends & Yields
NATCO Pharma Limited pays an annual dividend of ₹1.488, resulting in a dividend yield of 0.56%
Dividend Per Share₹1.488
Dividend Yield0.56%
Payout Ratio7.08%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.04
52-Week Price Change-3.49%
50-Day Moving Average848.91
200-Day Moving Average928.79
Relative Strength Index (RSI)38.65
Average Volume (3m)36.44K
Important Dates
NATCO Pharma Limited upcoming earnings date is Nov 17, 2026, TBA (Confirmed).
Last Earnings DateAug 14, 2026
Next Earnings DateNov 17, 2026
Ex-Dividend Date―
Financial Position
NATCO Pharma Limited as a current ratio of 3.01, with Debt / Equity ratio of 0.00%
Current Ratio3.01
Quick Ratio2.47
Debt to Market Cap0.04
Net Debt to EBITDA-0.48
Interest Coverage Ratio33.51
Taxes
In the past 12 months, NATCO Pharma Limited has paid 1.19B in taxes.
Income Tax1.19B
Effective Tax Rate0.08
Enterprise Valuation
NATCO Pharma Limited EV to EBITDA ratio is 9.86, with an EV/FCF ratio of 12.42.
EV to Sales4.19
EV to EBITDA9.86
EV to Free Cash Flow12.42
EV to Operating Cash Flow9.67
Balance Sheet
NATCO Pharma Limited has ₹21.29B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of ₹21.29B billion.
Cash & Marketable Securities₹21.29B
Total Debt₹0.00
Net Cash₹21.29B
Net Cash Per Share₹108.53
Tangible Book Value Per Share₹500.55
Margins
Gross margin is 76.14%, with operating margin of 30.16%, and net profit margin of 34.78%.
Gross Margin76.14%
Operating Margin30.16%
Pretax Margin37.70%
Net Profit Margin34.78%
EBITDA Margin42.52%
EBIT Margin37.45%
Analyst Forecast
The average price target for NATCO Pharma Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-20.73%
EPS Growth Forecast-32.59%